Baseline plasma HOTAIR and GAS5 levels were associated with responsiveness of DLBCL patients to standard R-CHOP therapy, with pretreatment HOTAIR was able to predict treatment failure. Here, GAS5 is linked to diffuse large B-cell lymphoma.